Matt (CBI Cohort of 2016) recently received his Ph.D. in chemistry under the direction of Prof. Paul J. Hergenrother. He is now a National Cancer Institute K00 postdoctoral fellow at Dana-Farber Cancer Institute/Harvard Medical School working in the laboratory of Prof. William G. Kaelin, Jr. His postdoctoral research will explore a variety of new ways of targeting mutant transcription factors found in cancer.